TVS Motor Company - Now in France
TVS Motor Company (TVSM) - a leading global automaker that operates in the two and three-wheeler segment - is showcasing its product range for Europe at the Salon du Deux Roues, Lyon till March 10, 2024. In being present at one of Europe’s premier auto expos, TVSM has announced its presence in France. The company has partnered with Emil Frey, a 100-year-old enterprise with extensive distribution network and deep market insights in Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240308987266/en/
TVS Motor Company zone at Salon du Deux Roues, Lyon in France (Photo: Business Wire)
TVSM is the world’s fourth largest two and three wheeler manufacturer, and the third most valued by market cap. Its products already sell in 80 countries.
The company is putting on display the TVS Apache RR 310, TVS Apache RTR 310, TVS Ronin, its electric scooters - TVS iQube S, TVS X, and its performance scooter - TVS NTORQ. The mobility show will be an opportunity for visitors to discover these models which are already approved for Europe. It will allow entities interested in marketing the brand in France to interact with the French and Indian TVS teams present on site.
Speaking on the participation, Sharad Mohan Mishra, President, Strategy, TVS Motor Company, said, “Our participation marks a significant milestone. Engaging with enthusiasts at this esteemed event enhances our visibility in France. We invite attendees to explore our pavilion and witness TVS Motor’s engineering, quality, and design prowess.”
Visitors are invited to the TVS Motor zone in stand 3B2 located in Hall 3.1 at the Salon du Deux Roues 2024.
PRODUCT DETAILS
- TVS X - the world's most advanced connected, electric scooter proudly made in India. This revolutionary machine sets a new benchmark in the global electric mobility industry with stunning design, unmatched performance & cutting-edge tech features, carving out a new category.
- TVS iQube - TVSM's flagship electric two-wheeler launched in 2020. It has led the mass adoption of EV mobility in India.
- TVS Apache 310 Series - a result of the symbiotic partnership with BMW, stands as a testament to international collaboration.
- TVS Ronin - a ‘modern-retro’ motorcycle, designed ground up and is a lifestyle statement that takes inspiration from the modern, new-age rider. It is designed with style, technology, and riding experience to promote an unscripted lifestyle.
- TVS NTORQ - a premium scooter that boasts of superior performance backed by TVS Racing Pedigree.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240308987266/en/
Contact information
Nikita Verma Nikita.Verma@tvsmotor.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Locate Bio Expands RESTORE Clinical Study to the United States Following FDA IDE Approval8.9.2025 09:00:00 EEST | Press release
Locate Bio, the UK-based regenerative medicine company reshaping rhBMP-2 perspectives, today announced that its RESTORE clinical study will expand into the United States following Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). Already underway across multiple sites in Australia, the study is evaluating Locate Bio’s lead product LDGraft in patients requiring anterior lumber interbody spinal fusion. LDGraft is an investigational bone graft substitute that encapsulates, rather than surface attaches, recombinant human Bone Morphogenetic Protein-2 (rhBMP-2). The design intent is to provide dose shielding of the rhBMP-2 during the early inflammatory phase of bone healing and to allow a greater proportion of the rhBMP-2 to be available during the subsequent repair phase. “We are thrilled to bring the RESTORE study to leading clinical centers in the United States,” said John von Benecke, CEO of Locate Bio. “We are very excited by the potential
AIR Brings World-Leading Inhalation Product Portfolio to InterTabac, as Demand for Shisha Surges Among Business Owners8.9.2025 09:00:00 EEST | Press release
Advanced Inhalation Rituals (AIR), the world’s leading social inhalation business, will be showcasing its most comprehensive portfolio to date at this year’s InterTabac, the world’s leading trade fair for tobacco products and smoking accessories, taking place from 18 – 20 September 2025 in Dortmund, Germany. From the heritage of Al Fakher, the world’s #1 shisha brand, to OOKA, AIR’s revolutionary charcoal-free shisha device, visitors to InterTabac will gain a first-hand look at how AIR is shaping the future of shisha. Visitors will be able to sample flavors, explore breakthrough technologies, and discover how our multi-category portfolio creates new opportunities for lounges, retailers, and distributors alike. The shisha market is not only growing – it’s evolving rapidly. AIR’s research shows that nine in ten (90%) businesses expect to see demand for shisha increase over the next two years, with strong optimism across the major markets of the UAE, US, Spain and Germany. Findings from A
U.S. FDA Approves Expanded Indication for VONVENDI ® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease6.9.2025 03:45:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Recombinant)], expanding the indication to include routine prophylaxis to reduce the frequency of bleeding episodes in adults with von Willebrand Disease (VWD), including those with Type 1 and 2 disease, and on-demand and perioperative management of bleeding in pediatric patients with VWD. VONVENDI was previously approved for on-demand and perioperative use in adults with VWD and routine prophylactic use in adults with severe Type 3 VWD receiving on-demand therapy.1 VONVENDI is now available for use in a broad range of VWD patients and is the only recombinant von Willebrand Factor (VWF) replacement therapy with approved indications in both adults and children with VWD.1 VWD is the most common bleeding disorder impacting more than 3 million people in the U.S. alone. It occurs equally among men
Samsung Unveils “AI Home: Future Living, Now” Vision at IFA 20256.9.2025 00:34:00 EEST | Press release
At Innovation For All (IFA) 2025, Samsung Electronics showcased its vision for “AI Home: Future Living, Now”. Samsung’s AI Home aims to be a reality people can experience today — not just in the future — and one designed for everyone, not just a select few. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250905654772/en/ Cheolgi Kim, Head of Digital Appliances, presents Future Living Now at Samsung’s IFA 2025 press conference in Berlin “At Samsung, we’re not just imagining the future of AI; we’re building it into everyday life. Samsung’s AI Home moves beyond smart devices to homes that truly understand you, adapt to your needs, and care for what matters most,” said Cheolgi Kim (CK), Executive Vice President and Head of Digital Appliances (DA) Business. “This is the beginning of a new era - where technology supports your life in the background so that you can live it more fully.” Samsung’s AI Home experience is designed to mak
NetApp named a Leader by Gartner® in the 2025 Magic Quadrant™ for Enterprise Storage Platforms5.9.2025 18:15:00 EEST | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced it has been recognized by Gartner as a Leader in the 2025 Gartner Magic Quadrant for Enterprise Storage Platforms. NetApp believes this recognition reflects how the company’s continuous innovation helps customers build Intelligent Data Infrastructure to face modern technology challenges, including protection from cyber threats and using AI to drive data-based decisions. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute. According to Gartner, “Enterprise storage platforms offer platform-native service capabilities and product features for both structured and unstructured data workloads. Heads of infrastructure and operations should use this research to assess vendors in deploying a modern IT infrastructure platform for block, file and object storage.” This report combines the previous Gartner Magic Quadrant reports for the Pri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom